Progressive multifocal leukoencephalopathy treated with nivolumab

Risk of Progressive Multifocal Leukoencephalopathy in the Combination Antiretroviral Therapy Era in the French Hospital Database on Human Immunodeficiency Virus (ANRS-C4)

(2018) Hugues Melliez et al.   CLINICAL INFECTIOUS DISEASES

Immune-Related Adverse Events Associated with Immune Checkpoint Blockade

(2018) Michael A. Postow et al.   NEW ENGLAND JOURNAL OF MEDICINE

Anti-PD-1/PD-L1 therapy for infectious diseases: learning from the cancer paradigm

(2017) Martin Rao et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Immune checkpoint inhibitor therapy

(2017) Ho Jin Kim et al.   NEUROLOGY

Preclinical disease activity in multiple sclerosis: A prospective study of cognitive performance prior to first symptom

(2016) Marianna Cortese et al.   ANNALS OF NEUROLOGY

Progressive multifocal leukoencephalopathy therapy

(2014) David B. Clifford   JOURNAL OF NEUROVIROLOGY

Increased Program Cell Death–1 Expression on T Lymphocytes of Patients With Progressive Multifocal Leukoencephalopathy

(2012) Chen Sabrina Tan et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Progressive multifocal leukoencephalopathy in transplant recipients

(2011) Farrah J. Mateen et al.   ANNALS OF NEUROLOGY